As I receive a lot of my funding from the U.S., I have to abide by the equivalent of Bill C-11 with the select agent rule. That's a little different because pathogens are considered select agents not based on their risk group. So you can be a risk group two pathogen and still be a select agent, and then you are governed by the select agent rule, whereas in Canada you would be a risk group two pathogen, and some risk group two pathogens would certainly be treated even under Bill C-11 with less concern than they would be if they were being handled in the U.S.
On March 12th, 2009. See this statement in context.